Your Custom Text Here
Novartis AG NVS +1.16% thinks its best bet for testing two new Alzheimer’s drugs is on people who don’t actually have Alzheimer’s.
The Swiss drug giant is looking for people whose genes put them at high risk of developing Alzheimer’s, but who haven’t yet fallen victim to the mind-robbing disease. It hopes such early treatment proves more successful than past efforts to tackle the disease once it has taken hold.
People with a brain injury or dementia often struggle to remember simple things, like names or places. In research published Thursday in the journal Current Biology, scientists have shown it may be possible to improve this sort of memory using tiny pulses of electricity — if they're properly timed.
A typical person's ability to remember things tends to vary a lot, says Michael Kahana, who directs the computational memory lab at the University of Pennsylvania.
The exact mechanisms underlying the devastation that is Alzheimer’s Disease (AD) are not entirely understood, but researchers do know that inflammation in the brain is related to the onset of the disease. Now, through a basic eye exam, clinicians may be able to spot AD warning signs, including inflammation, long before symptoms appear
Alzheimer's doesn't have to be your brain's destiny, says neuroscientist and author of "Still Alice," Lisa Genova. She shares the latest science investigating the disease — and some promising research on what each of us can do to build an Alzheimer's-resistant brain.
The 2017 Aspen Summit on Inequality & Opportunity brought together a diverse mix of policymakers, thought leaders, social entrepreneurs, philanthropists, and practitioners to address the nation’s widening opportunity gap. Tucked between to-be-expected panels on manufacturing and hunger, was a 15 minute talk by Dr. Sarah Enos Watamura, Associate Professor of Psychology at the University of Denver and Director of the Child Health & Development Lab, on the biology of adversity. She opened by posing the question: How could a consideration of biology inform policy and practice solutions for moving families from inequality to opportunity?
More people are living longer these days, but the good news comes shadowed by the possible increase in cases of age-related mental decline. By some estimates, the global incidence of dementia will more than triple in the next 35 years. That grim prospect is what makes a study published in March in The Journal of Alzheimer’s Disease so encouraging: It turns out that regular walking, cycling, swimming, dancing and even gardening may substantially reduce the risk of Alzheimer’s.
A Place for Mom recently celebrated the stories of three exceptional caregivers: Carlen Maddux, Feylyn Lewis and Susan Hamilton. Although each of these caregivers had a very different and unique caregiving experience, they all shared similar tips about how caregivers can survive and triumph.
Despite the collapse of Republicans’ ObamaCare repeal effort, the health care issue isn’t going away.
The current health care debate in Washington is fundamentally one over who pays. However, it won’t matter whether Medicare, Medicaid, private insurers or individuals pick up the tab, if the most urgent challenge in health care is left out of the next debate in Congress.
Workers who perform in-home services for disabled or elderly individuals have special rules when tax time rolls around. But, understanding who the IRS considers the caregiver’s employer is one critical part of these tax rules that confuses many caregivers.
If you’ve ever spent the night in a hospital, you’re likely aware of the preponderance of alarms designed to alert healthcare practitioners about potentially life-threatening events. And while the point of these alarms is to help healthcare providers do their jobs, the reality is that these alarms can at times be more harmful than helpful. Why? Because of a phenomenon known as “alarm fatigue.” Here’s a closer look at the problem, along with research underway aimed at improving patient safety by reducing alarm fatigue.
‘If we had put a war on neurologic diseases at the same time we declared a war on cancer, we probably would not be having this conversation.” Those are the wise words of Janet Woodcock, director of the Food and Drug Administration’s Center for Drug Evaluation and Research, before Congress last month.
Despite its heroic intentions to protect us against foreign invaders, inflammation also plays a role in many diseases, especially those experienced by older adults. Doctors and researchers around the world and across disease categories have caught on, and they’re working on ways to tame the beast of chronic inflammation.
“More than 90 percent of all noncommunicable diseases of aging are associated with chronic inflammation,” David Furman of Stanford Medical School’s Institute for Immunity, Transplantation and Infection explained upon the release of a study on caffeine consumption and inflammation.